APOL1 and focal segmental glomerulosclerosis: Recent case reports of new or relapsing glomerular disease temporally associated with SARS-CoV-2 vaccination include focal segmental glomerulosclerosis, minimal change disease, IgA nephropathy, antineutrophilic cytoplasmic antibody-associated glomerulonephritis, membranous nephropathy, lupus nephritis, and anti-glomerular basement membrane disease.4, 5, 6,14,15 African American/Black persons with APOL1 HRG are underrepresented in these studies.